FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy.
Genes (Basel)
; 10(4)2019 04 04.
Article
de En
| MEDLINE
| ID: mdl-30987397
ABSTRACT
Pharmacogenetic (PGx) guidelines for the precise dosing and selection of drugs remain poorly implemented in current clinical practice. Among the barriers to the implementation process is the lack of clinical decision support system (CDSS) tools to aid health providers in managing PGx information in the clinical context. The present study aimed to describe the first Italian endeavor to develop a PGx CDSS, called FARMAPRICE. FARMAPRICE prototype was conceived for integration of patient molecular data into the clinical prescription process in the Italian Centro di Riferimento Oncologico (CRO)-Aviano Hospital. It was developed through a coordinated partnership between two high-tech companies active in the computerization of the Italian healthcare system. Introducing FARMAPRICE into the clinical setting can aid physicians in prescribing the most efficacious and cost-effective pharmacological therapy available.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Ordonnances médicamenteuses
/
Systèmes d'aide à la décision clinique
/
Variants pharmacogénomiques
Type d'étude:
Guideline
/
Health_economic_evaluation
/
Prognostic_studies
Limites:
Humans
Pays/Région comme sujet:
Europa
Langue:
En
Journal:
Genes (Basel)
Année:
2019
Type de document:
Article
Pays d'affiliation:
Italie